Wells Fargo Reiterates Equal-Weight Rating on Domino's Pizza, Inc. (DPZ)
Rating Change Wells Fargo analysts reiterated a Equal-Weight rating on Domino's Pizza, Inc. (NASDAQ:DPZ) on July 21, 2026. Market Context Domino's Pizza, Inc.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Wells Fargo analysts reiterated a Equal-Weight rating on Domino's Pizza, Inc. (NASDAQ:DPZ) on July 21, 2026. Market Context Domino's Pizza, Inc.
Read moreRating Change RBC Capital analysts reiterated a Sector Perform rating on Domino's Pizza, Inc. (NASDAQ:DPZ) on July 21, 2026. Market Context Domino's Pizza, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Domino's Pizza, Inc. (NASDAQ:DPZ) on July 21, 2026. Market Context Domino's Pizza, Inc.
Read moreRating Change Susquehanna analysts reiterated a Neutral rating on Live Nation Entertainment, Inc. (NYSE:LYV) on July 21, 2026. Market Context Live Nation Entertainment, Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Live Nation Entertainment, Inc. (NYSE:LYV) on July 21, 2026. Market Context Live Nation Entertainment, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Kenvue Inc. (NYSE:KVUE) on July 21, 2026. Market Context Kenvue Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Old Dominion Freight Line, Inc. (NASDAQ:ODFL) on July 21, 2026. Market Context Old Dominion Freight Line, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Kimberly-Clark Corporation (NASDAQ:KMB) on July 21, 2026. Market Context Kimberly-Clark Corporation operates in…
Read moreRating Change BMO Capital analysts initiated coverage on MapLight Therapeutics, Inc. (NASDAQ:MPLT) with a Outperform rating on July 21, 2026. Market Context MapLight Therapeutics,…
Read moreRating Change UBS analysts reiterated a Buy rating on MapLight Therapeutics, Inc. (NASDAQ:MPLT) on July 21, 2026. Market Context MapLight Therapeutics, Inc.
Read moreRating Change Canaccord Genuity analysts initiated coverage on Brazil Potash Corp. (NYSE:GRO) with a Speculative Buy rating on July 21, 2026. Market Context Brazil Potash Corp.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Centerspace (NYSE:CSR) on July 21, 2026. Market Context Centerspace operates in the Real Estate sector. The…
Read moreRating Change UBS analysts initiated coverage on ATRenew Inc. (NYSE:RERE) with a Buy rating on July 21, 2026. Market Context ATRenew Inc.
Read moreRating Change Scotiabank analysts reiterated a Sector Perform rating on Douglas Emmett, Inc. (NYSE:DEI) on July 21, 2026. Market Context Douglas Emmett, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Douglas Emmett, Inc. (NYSE:DEI) on July 21, 2026. Market Context Douglas Emmett, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Genesis Energy, L.P. (NYSE:GEL) on July 21, 2026. Market Context Genesis Energy, L.P.
Read moreRating Change Jones Trading analysts reiterated a Buy rating on Dynex Capital, Inc. (NYSE:DX) on July 21, 2026. Market Context Dynex Capital, Inc.
Read moreRating Change Benchmark analysts initiated coverage on Stewart Information Services Corporation (NYSE:STC) with a Buy rating on July 21, 2026. Market Context Stewart Information…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Delek US Holdings, Inc. (NYSE:DK) on July 21, 2026. Market Context Delek US Holdings, Inc.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ:TARS) on July 21, 2026. Market Context Tarsus Pharmaceuticals, Inc.
Read more